Bellevue Group AG 13D and 13G filings for Jade Biosciences, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-08-14 11:57 am Sale | 2026-06-30 | 13G | JADE BIOSCIENCES, INC. JBIO | Bellevue Group AG | 3,057,996 5.000% | -283,107 (-8.47%) | Filing |
| 2026-02-17 4:01 pm Purchase | 2025-12-16 | 13G | JADE BIOSCIENCES, INC. JBIO | Bellevue Group AG | 3,341,103 6.800% | 3,341,103 (New Position) | Filing |